This is a phase I study assessing the safety and tolerability of single dose of a study drug which is being developed for the treatment of hyperuricemia and gout.
Eligible participants will be required to stay in the clinical unit for a total of 5 nights and 6 days.
Participants must meet the following criteria:
Male between the ages of 18 and 50
BMI must be between 18 – 30 kg/m2
Currently not taking any medications with no allergies to any drugs
Free from any clinically significant illness or disease as determined by medical history
Remuneration is offered to eligible participants.
Click here to register for our clinical trials.